MarrowStim Concentration Kit Peripheral Arterial Disease (PAD) Study
An FDA-Approved Clinical Trial
The MarrowStim Concentration Kit PAD Study is an approved Food and Drug Administration (FDA) Phase I clinical trial. The purpose of this research is to study a new treatment using a patient's own concentrated bone marrow aspirate in those suffering from severe peripheral arterial disease (PAD). The concentrated bone marrow aspirate is prepared using the MarrowStim Concentration Kit.
Concentrated bone marrow aspirate contains mononuclear cells that may have the potential to create new vascular structures. Study participants will receive multiple injections of concentrated bone marrow aspirate harvested from their iliac crest during ischemic limb surgery. Study patients will be treated at the Indiana University School of Medicine in Indianapolis, Indiana.
Only those patients meeting the pre-defined approved inclusion/exclusion criteria are eligible for this clinical trial. In many cases, patients who qualify for this trial have been told previously that surgery was not a treatment option.
Call toll free 1-877-PAD-STUDY (1-877-723-7883) for more information or contact Janet Klein, RN, MSN via email at firstname.lastname@example.org.
|MarrowStim Concentration Device||Patient receiving treatment.|
Indiana University School of Medicine
Principal Investigator: Michael Murphy, MD
Sub-Investigator: Keith March, MD, PhD
Research Coordinator: Janet Klein, RN, MSN email@example.com
Janet Klein, RN, MSN
For additional information, please refer to the ClinicalTrials.gov website at the following link: http://clinicaltrials.gov/ct2/show/NCT00113243